Stock 6622 ZHAOKE OPHTHALMOLOGY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Zhaoke Ophthalmology Limited

Equities

6622

KYG989M51017

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:42 2024-06-28 EDT 		5-day change 1st Jan Change
1.41 HKD +0.71% Intraday chart for Zhaoke Ophthalmology Limited 0.00% -64.30%
04-29 Zhaoke Ophthalmology Shrinks Loss in 2023 MT
04-08 Zhaoke Ophthalmology Limited Announces the Resignation of Chen Yu Has as Non-Executive Director CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zhaoke Ophthalmology's Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children
AQ
Vyluma Announces Positive Results From Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children
AQ
Zhaoke Ophthalmology Announces 2022 Interim Results
AQ
Zhaoke Ophthalmology Completed Patient Enrollments for the Phase III Clinical Trials of the Myopia Progression Treatment Drug NVK002
AQ
Zhaoke Ophthalmology : Two Products of Zhaoke Ophthalmology (6622.HK) Passed The On-Site Inspection for Drug Registration of The National Medical Products Administration and The GMP Compliance Inspection of The Guangdong Medical Products Administration
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6622 Stock
  4. News Zhaoke Ophthalmology Limited
  5. Press Releases